Seroba Life Sciences
Venture capitalDublin · Seed–Late Stage · 13 people tracked
Also known as SEROBA LIFE SCIENCES LIMITED PARTNERSHIP
Investment thesis
Seroba is a Dublin-based life sciences venture capital firm investing in early-stage biotech and medtech companies developing new therapeutics and medical devices.
Source: firm website, verified Aug 3, 2026.
Team · 13 people
from the firm's website & public directories
What they invest in
from 16 of 31 portfolio companiesHealthtech ×13Medical Devices ×12Biotech ×10Hardware ×3Deep Tech ×2Digital Health ×2AI & Machine Learning ×1Consumer ×1
HQs:United States×6Ireland×3Germany×2Denmark×1Italy×1
Investments · 31 tracked
founders shown can be your intro pathBy year:2024 · 12019 · 12 dated
Loci Orthopaedics develops extremity orthopaedic technologies, including its InDx device for the thumb base joint, using evidence-based design to address unmet clinical needs.
HealthtechMedical DevicesGalway, IE
Brendan Boland(Co-founder & Executive Chairperson)Barry(CEO)Paul(Finance Leader)John(VP Technical Operations)Karin(Medical Affairs / Clinical Development)Gerry(Co-founder)
Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.
AI & Machine LearningBiotechDeep TechTrento, IT
Emiliano Biasini(Co-founder)Pietro Faccioli(Co-founder)Giovanni Spagnolli(Co-founder, CTO)Maria Letizia Barreca(Co-founder)Graziano Lolli(Co-founder)
BiotechPhiladelphia, US
Raj Kannan(Executive Officer, Director)
BoardClaudio Nessi(Director)Ivan Gergel(Director)Jan Van de Bossche(Director)Garrett Ingram(Director)Gregory Parekh(Director)
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.
BiotechDigital HealthHealthtechMedical DevicesMunich, DE
Rafiq Hasan(CEO and Managing Director)Muhammad Ali Memon(Chief Medical Officer)
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery sensor and remote monitoring platform for managing NYHA class III heart failure.
Digital HealthHealthtechMedical DevicesWoodridge, US
Jonathan Jonas(Director)Harry Rowland(Executive Officer, Director)Raymond S. Barrett, Jr.(Director)Anthony I Nunez(Executive Officer, Director)Sam R. Leno(Director)Leslie A. Saxon(Director)
Fusion Pharma develops targeted alpha therapeutics for cancer treatment using proprietary linker technology to connect alpha-emitting medical isotopes to cancer-targeting molecules, delivering lethal damage to tumor cells while minimizing toxicity to healthy tissues.
BiotechHealthtechMedical Devices
Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy.
Deep TechHealthtechMedical DevicesGalway City, IE
Wayne Allen(Co-Founder, CEO, Director)Liam Mullins(CTO and Co-founder)
HealthtechSunnyvale, US
Richard Ferrari(Executive Officer, Director)David Neustaedter(Director)Kenneth Hayes(Director)James Joye(Executive Officer, Director)Chris Owens(Director)
BoardDaniel O'Mahony(Director)
PrecisionBiotics develops food supplements containing specific bacterial strains aimed at supporting gut health and the microbiome for consumers and clinicians, alongside educational resources on gut health.
BiotechConsumerHealthtechWellness & Fitness
Lundbeck is a global pharmaceutical company specializing in researching, developing, manufacturing, and commercializing medications for brain diseases and neurological conditions.
BiotechHealthtechMedical DevicesCopenhagen, DK
Quanta develops the Quanta Dialysis System, a compact, modular hemodialysis machine designed for flexible kidney care in acute and chronic facilities.
HardwareHealthtechMedical DevicesBurbank, US
ERIC RICE(Executive Officer)JEFFREY DOIRON(Executive Officer)BLAKE GILETTE(Executive Officer)KIRK WESTWOOD(Executive Officer)
Ryme Medical develops a catheter-based therapy to treat chronic obstructive pulmonary disease (COPD) by reducing airway inflammation and improving patient outcomes.
BiotechHealthtechMedical DevicesMountain View, US
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)Zack Scott(Director)Brad Vale(Director)Casey Tansey(Director)Mudit Jain(Executive Officer, Director)
STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.
BiotechHealthtechMedical Devices
Exits · 1
IPOs and acquisitions across the tracked portfolioPrexton Therapeuticsacq. by Lundbeck
Frequently asked questions
- What stage does Seroba Life Sciences invest at?
- Seroba Life Sciences invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Seroba Life Sciences's typical check size?
- Seroba Life Sciences typically writes checks of $540K – $7.6M.
- What sectors does Seroba Life Sciences focus on?
- Seroba Life Sciences focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Seroba Life Sciences located?
- Seroba Life Sciences is headquartered in Dublin, IE.
Media · Podcasts & interviews
featuring the teamBruno MONTANARI, Partner, SEROBA LIFE SCIENCES
IPEM · Bruno Montanari
Co-investors · 12
Molten Ventures is a European venture capital firm that backs technology founders from Series A onward, providing capital along with operational expertise, networks, and partnership to help companies scale globally.
Forbion is a global venture capital firm focused on advancing biotech innovations and sustainable solutions aimed at improving human and planetary health.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
3B Future Health Fund invests in early-stage private healthcare and biotech companies in the US, Europe and Israel that address high unmet patient needs, with a focus on oncology and rare diseases.
Claris Ventures is an early-stage investor that makes equity investments in biopharma companies with strong scientific evidence and a clear vision.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Earlybird Venture Capital is a European venture capital firm that backs early-stage technology founders with capital, strategic support, and access to an international network.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
Atlantic Bridge is a growth equity firm investing in deep technology companies across Europe, the UK and the US, using a cross-border value-add strategy and a global platform to help portfolio companies scale internationally.
venBio is a life sciences venture capital firm that partners with industry leaders to develop novel therapeutics and technologies addressing unmet medical needs.
Karista is a French venture capital firm that invests in tech and early-stage companies, frequently leading funding rounds and supporting founders through strategic guidance and board involvement.
Borski Fund is a venture capital fund that invests in gender-diverse, female-(co)-led companies in the Netherlands and UK, aiming to improve access to financial and social capital for founders.
Firms observed investing alongside Seroba Life Sciences, from public investor directories. Shared companies are the overlap with Seroba Life Sciences's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
Portfolia operates thematic venture capital funds designed for women investors, backing companies in areas such as women's health, longevity, active aging, greentech, and fintech, while offering an educational and community-driven investing experience.